Skip to content

Effectivenes of lignocaine spray

Effectiveness of paracervical block verses local lignocaine spray along with intrauterine instillation for analgesia in office gynaecological procedures: An Assessor blinded Randomized Controlled Trial. - Nil

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110713
Enrollment
52
Registered
2026-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N926- Irregular menstruation, unspecified

Interventions

Intervention1: Paracervical block with lignocaine: Following a negative sensitivity test, patients will receive a total of 10 mL of 2% lignocaine (Neon) administered as a paracervical block. The inje

Sponsors

Government of Institute of Medical Sciences (GIMS)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Women aged 18 55 years requiring one of the above office gynecological procedures. 2.Ability to provide informed consent.

Exclusion criteria

Exclusion criteria: Known allergy/ hypersensitivity to lignocaine. Pregnancy and lactation Cervical stenosis/prior cervical surgery -Active Pelvic inflammatory diseases -Coagulopathy or anticoagulant therapy. -Severe cardiovascular or hepatic disease. -Psychiatric illnesses that would interfere with perception and assessment of pain

Design outcomes

Primary

MeasureTime frame
1.Pain score measured on a 100 mm Visual Analogue Scale (VAS, 0 10) at different time points and Onset of analgesia in both technique and Duration of analgesia in both technique Timepoint: -Immediately after the procedure -Within 30 mins post procedure -At 60 mins post procedure

Secondary

MeasureTime frame
1.Adverse events such as hypotension -more than 20 percent fall from baseline, bradycardia -less than 60 per minute , bleeding, nausea , vomiting, giddiness, fainting, allergic reactions] associated with each group. 2.Need for rescue analgesia 3.Duration of the procedureTimepoint: From baseline to end of study procedure

Countries

India

Contacts

Public ContactDr Labhanki Sharma

Government Institute of Medical Sciences(GIMS)

drritu661@gmail.com9717001590

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026